A method of providing immunostimulation by activation of one or more dendritic cells (DCs) to a human subject for a prophylaxis, a therapy or a combination thereof against one or more viral, bacterial, fungal, parasitic, protozoal, and parasitic diseases, and allergic disorders comprising the steps of:
- identifying the human subject in need of immunostimulation for the prophylaxis, the therapy or a combination thereof against the one or more diseases selected from the group selected from influenza, HIV, cancer, and immune disorders;
- isolating one or more DCs from the human subject;
- activating the isolated DCs with an amount of a composition effective for form activated DCs comprising:
- an antigen;
- and
- an adjuvant, wherein the adjuvant comprises an anti-dendritic cell (DC)-specific antibody or fragment thereof conjugated to a Toll-Like Receptor (TLR) agonist;
- and a pharmaceutically acceptable carrier, wherein the conjugate and agonist are each comprised in an amount such that, in combination with the other, are effective to produce the immune response in a human or animal subject in need of immunostimulation;
- and
- reintroducing the activated DCs into the human subject.